Home Genetic Immunity

Genetic Immunity

acquired
-
A U.S./Hungary-based clinical-stage biotechnology company

Basic Information

Genetic Immunity is a U.S./Hungary-based clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel immunotherapeutic biologics ("immunotherapies" or "therapeutic vaccines") for the treatment of chronic viral infections, cancer, and allergies. Genetic Immunity's immunotherapies are designed to strengthen or enhance specific immune responses to modify or control these currently incurable diseases.
Genetic Immunity Inc
United States of America
less than 15 people
January 01, 1998
info@geneticimmunity.com